Safety and immunogenicity of investigational tuberculosis vaccine M72/AS01E–4 in people living with HIV in South Africa: an observer-blinded, randomised, controlled, phase 2 trial
Titel:
Safety and immunogenicity of investigational tuberculosis vaccine M72/AS01E–4 in people living with HIV in South Africa: an observer-blinded, randomised, controlled, phase 2 trial
Auteur:
Dagnew, Alemnew F Han, Linda L Naidoo, Kogieleum Fairlie, Lee Innes, James C Middelkoop, Keren Tameris, Michele Wilkinson, Robert J Ananworanich, Jintanat Bower, Daniel Schlehuber, Lisa Frahm, Nicole Cinar, Amy Dunne, Michael Schmidt, Alexander C
Verschenen in:
The Lancet. HIV
Paginering:
Jaargang 12 () nr. 8 pagina's e546-e555
Jaar:
2025
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license